1,494 results on '"Velazquez, Eric J."'
Search Results
2. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
3. Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial
4. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial
5. The Impact of Ejection Fraction on Major Adverse Limb Events after Lower Extremity Revascularization
6. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF
7. A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST).
8. Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review
9. Abstract 15754: The Incidence and Effect of Cardiac Function Decline After Lower Extremity Revascularization
10. Abstract 15167: The Use of Echocardiography in Patients With Advanced Peripheral Arterial Disease
11. Abstract 14826: Effect of Torsemide vs Furosemide After Discharge for Acute Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: Observations From Transform-HF
12. Abstract 14756: The Effect of Torsemide vs Furosemide Across the Renal Function Spectrum - Insights From the TRANSFORM-HF Trial
13. Abstract 14698: Effect of Torsemide vs. Furosemide Among Patients With New Onset and Worsening Heart Failure: The Transform-HF Randomized Trial
14. Abstract 14618: Comparative Outcomes of Elective Endovascular Abdominal Aortic Aneurysm Repair in Patients With Preoperative Cardiac Stress Testing
15. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
16. Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event
17. Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study
18. Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction
19. Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial
20. Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images
21. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial
22. On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF
23. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy
24. Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy
25. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial
26. PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes
27. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF)
28. Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study
29. The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial
30. Association of COVID-19 Hospitalization Volume and Case Growth at US Hospitals with Patient Outcomes
31. Abstract 14375: Guideline Directed Medical Therapy After Peripheral Vascular Intervention and Association With Long-Term Outcomes at an Academic Health System
32. Abstract 14057: Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images
33. Abstract 13818: Health System Integrated Measurement-Based Care Using Patient-Reported Outcomes Assessment in Lower-Extremity Peripheral Artery Disease
34. Abstract 12311: The Impact of Ejection Fraction on Major Adverse Limb Events After Lower Extremity Revascularization
35. Abstract 11232: Coronary Artery Bypass Graft Surgery Shows Improved Restricted Mean Survival Time and Time Lost Compared to Medical Therapy in Patients With Left Ventricular Dysfunction: From the STICH Trial
36. Abstract 10253: Integrating Mental Health Screening Into a Health System for Measurement-Based Care of Patients With Peripheral Artery Disease
37. REVeAL-HF: Design and Rationale of a Pragmatic Randomized Controlled Trial Embedded Within Routine Clinical Practice
38. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial
39. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)
40. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT
41. Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial
42. Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial
43. A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression.
44. Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study.
45. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.
46. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation
47. Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure
48. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure
49. Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic Stenosis
50. The Impact of Ejection Fraction on Major Adverse Limb Events after Lower Extremity Revascularization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.